본문바로가기

About

  • About
  • History
  • 2020`s

    2024

    08 KOSDAQ listing

    01

    2023

    12

    11 CE- MDER certification (Nexpowder)

    04

    02 Approval of IND(Korea) for Nexsphere-F

    2022

    12 Singapore HSA approval for Nexpowder

    11 World-class Product of Korea 2022 (Nexpowder)

    10 Canada Health Clearance for Nexpowder

    09 US FDA Clearance for Nexpowder

    06 MDSAP Registration

    2021

    04 Reimbursement approval by National Health Insurance, Korea (Nexpowder)

    2020

    12 Korea Innovative medical device company designation by Ministry of Health and Welfare (MOHW)

    10 First shipment to Medtronic (Nexpower)

    09 US FDA 510k submission for Nexpowder

    07 Global supply and distribution agreement with Medtronic (Nexpowder)

    04 CE certification (Nexsphere)

  • 2010`s

    2019

    11 Innovative icon company designation by Korea Credit Guarantee Fund (KODIT)

    06 Quality Collaboration Agreement with Medtronic

    06 Relocation of new corporate building in Songdo

    06 Medical device manufacture approval by Ministry of Food and Drug Satefy (MFDS) (Nexsphere)

    01 New health technology approval by National Evidence-based Healthcare Collaborating Agency (NECA)

    2018

    12 CE certification (Nexpowder)

    01 Medical device manufacture approval by MFDS (Nexpowder)

    2015

    07 Certification of venture company/Establishment of R&D Center

    06 GMP certification by MFDS

    2014

    08 Establishment of NEXTBIOMEDICAL CO., LTD.